Hims & Hers Health, Vertex Pharmaceuticals, Eli Lilly and Company, UnitedHealth Group, and AbbVie are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of companies operating in the healthcare and life-sciences sectors, including pharmaceuticals, biotechnology, medical device manufacturers and healthcare service providers. By buying these equities, investors gain ownership stakes in firms involved in drug discovery, clinical trials, medical technology development and patient care. Their performance often hinges on factors like regulatory approvals, research breakthroughs and broader public-health trends. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Shares of Hims & Hers Health stock traded up $4.86 during midday trading on Tuesday, hitting $46.74. The company had a trading volume of 100,935,081 shares, compared to its average volume of 17,370,167. Hims & Hers Health has a 1-year low of $11.45 and a 1-year high of $72.98. The business's 50 day simple moving average is $32.22 and its two-hundred day simple moving average is $31.70. The stock has a market cap of $10.38 billion, a PE ratio of 106.00 and a beta of 1.84.
Read Our Latest Research Report on HIMS
Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor.
NASDAQ VRTX traded down $64.66 during midday trading on Tuesday, hitting $435.53. The company had a trading volume of 4,673,578 shares, compared to its average volume of 1,558,250. The firm has a fifty day simple moving average of $492.42 and a two-hundred day simple moving average of $466.91. Vertex Pharmaceuticals has a fifty-two week low of $377.85 and a fifty-two week high of $519.88. The company has a quick ratio of 2.35, a current ratio of 2.69 and a debt-to-equity ratio of 0.01. The stock has a market cap of $111.97 billion, a price-to-earnings ratio of -197.82, a P/E/G ratio of 2.11 and a beta of 0.51.
Read Our Latest Research Report on VRTX
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of NYSE LLY traded down $36.98 during mid-day trading on Tuesday, hitting $784.48. The company had a trading volume of 2,220,082 shares, compared to its average volume of 3,470,828. Eli Lilly and Company has a 12 month low of $677.09 and a 12 month high of $972.53. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.15 and a quick ratio of 0.97. The firm has a market cap of $743.82 billion, a P/E ratio of 67.00, a PEG ratio of 1.40 and a beta of 0.51. The business's 50-day simple moving average is $823.48 and its 200-day simple moving average is $814.29.
Read Our Latest Research Report on LLY
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Shares of NYSE UNH traded down $8.73 during trading hours on Tuesday, reaching $396.08. The stock had a trading volume of 3,383,374 shares, compared to its average volume of 4,621,386. UnitedHealth Group has a twelve month low of $393.11 and a twelve month high of $630.73. The company has a market cap of $360.52 billion, a price-to-earnings ratio of 25.56, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business's fifty day moving average is $494.68 and its two-hundred day moving average is $527.03.
Read Our Latest Research Report on UNH
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
NYSE:ABBV traded down $8.00 during mid-day trading on Tuesday, hitting $188.07. The company's stock had a trading volume of 3,856,202 shares, compared to its average volume of 6,070,580. The company has a current ratio of 0.66, a quick ratio of 0.55 and a debt-to-equity ratio of 17.94. The stock has a fifty day moving average of $196.00 and a 200-day moving average of $187.27. The company has a market capitalization of $332.69 billion, a price-to-earnings ratio of 78.20, a P/E/G ratio of 1.62 and a beta of 0.56. AbbVie has a fifty-two week low of $153.58 and a fifty-two week high of $218.66.
Read Our Latest Research Report on ABBV
Recommended Stories
Before you consider Hims & Hers Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hims & Hers Health wasn't on the list.
While Hims & Hers Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
